Setsuko Chambers

Procollagen-derived biomarkers in malignant ascites of ovarian cancer. Independent prognosticators for progression-free interval and survival.

Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure.

An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells that express little glucocorticoid receptor.

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.

Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.

Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome.

SGK1, a potential regulator of c-fms related breast cancer aggressiveness.

Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved.

Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype.

Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis.

Precursors of endometrial clear cell carcinoma.

Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.

Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.

The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.

Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.

HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.

Biomarker targets and novel therapeutics.

Role of CSF-1 in progression of epithelial ovarian cancer.

Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger.

Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review.

Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.

Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.

Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.

Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer.

Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.

Tubal origin of 'ovarian' low-grade serous carcinoma.

Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.

Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.

Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer.

The significance of p53 isoform expression in serous ovarian cancer.

Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.

An unusual BRCA mutation distribution in a high risk cancer genetics clinic.

Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.

Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.

Tubal origin of ovarian endometriosis.

Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.

Simultaneous multiplane imaging of human ovarian cancer by volume holographic imaging.

Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904.

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.

Tubal origin of ovarian low-grade serous carcinoma.

Confocal microlaparoscope for imaging the fallopian tube.

Evaluation of a hypoxia regulated gene panel in ovarian cancer.

Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.

Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer Detection.

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.

Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer.

Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection.

Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy.

Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI.

Expression of the cytoplasmic nucleolin for post-transcriptional regulation of macrophage colony-stimulating factor mRNA in ovarian and breast cancer cells.